Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome


Akinci B., Celtik A. , YÜKSEL F., Genc S., Yener S., Secil M., ...Daha Fazla

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.91, ss.26-31, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 91 Konu: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.diabres.2010.09.028
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Sayfa Sayıları: ss.26-31

Özet

Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has been shown to link cardiovascular disorders. The aim of this study is to investigate the potential relationship between serum OPG levels, cardiovascular risk factors and metabolic syndrome in a relatively large group of women with previous GDM.